While there were some differences in the GSK3β-inhibitory effect among the drugs and cell lines, the CLOVA cocktail decreased the level of pGSS641 in all GBM cells more efficiently than each of the cocktail constituents (Figure 2A). Here, GSK3B is linked to glioblastoma.